A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
PHASE3
The study is being conducted to evaluate the tolerability, safety and effic...
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE3
To evaluate whether Fuzuloparib plus AA-P is superior to placebo plus AA-P ...
The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer.
PHASE2
Preclinical data support the investigation of PARP inhibitors in other neop...
Status
Unknown
Location
Department of Colorectal Surgery Fudan University Shanghai Caner Center